Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Iodine-based oral rinse - Biomedical Development Corporation

Next Previous
Drug Profile

Iodine-based oral rinse - Biomedical Development Corporation

Alternative Names: Frio mouth rinse; Frio oral rinse; iCLEAN/FRIO; Iocide; Iocide oral rinse

Latest Information Update: 12 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biomedical Development Corporation
  • Developer Biomedical Development Corporation; Foundation Of Collaborative Unique Science; Methodist Healthcare Ministries of South Texas; National Institute of Nursing Research
  • Class Anti-infectives; Disinfectants; Halogens; Urinary anti-infective agents
  • Mechanism of Action Endotoxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Gingivitis
  • No development reported Candidiasis; Periodontitis; Urinary tract infections

Most Recent Events

  • 28 Apr 2018 No recent reports of development identified for phase-I development in Candidiasis in USA (PO, Gargle)
  • 28 Apr 2018 No recent reports of development identified for phase-I development in Periodontitis in USA (PO, Gargle)
  • 28 Apr 2018 No recent reports of development identified for phase-I development in Urinary-tract-infections in USA (PO, Gargle)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top